ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, S.-i.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2005;79:1142-1146
© 2005 The Society of Thoracic Surgeons

Original articles: General thoracic

Impact of Large Tumor Size on Survival After Resection of Pathologically Node Negative (pN0) Non–Small Cell Lung Cancer

Shin-ichi Takeda, MDa,*, Shimao Fukai, MDb, Hikotaro Komatsu, MDc, Etsuo Nemoto, MDd, Kenji Nakamura, MDe, Masaru Murakami, MDf, Japanese National Chest Hospital Study Group

a Toneyama National Hospital, Osaka
b Ibaragi East National Hospital, Ibaragi
c Tokyo National Hospital, Tokyo
d Minami Yokohama National Hospital, Yokohama
e Ehime National Hospital, Ehime
f Tenryu National Hospital, Shizuoka, Japan

Accepted for publication September 7, 2004.

* Address reprint requests to Dr Takeda, Toneyama National Hospital, Toneyama 5–1–1, Toyonaka, Osaka, 560–8552 Japan (E-mail: stakeda{at}toneyama.hosp.go.jp).

BACKGROUND: The current TNM staging system first adopted the tumor size of 3 cm for subdivision of stage I and II disease. The aim of the present study was to evaluate the impact of tumor size on survival in patients with pathologically node negative (pN0) non–small cell lung cancer after complete resection.

METHODS: We retrospectively reviewed the records of 603 patients with pN0 non–small cell lung cancer patients (403 men and 200 women) who underwent a complete resection in five national chest hospitals between 1992 and 1996, with follow-up duration of more than 5 years, and analyzed tumor size and survival. Survival rate was estimated by the Kaplan-Meier method, and differences were compared by log-rank test. For the multivariate analysis, the Cox proportional hazard model was used to identify variables that significantly affected survival.

RESULTS: There were 355 adenocarcinomas, 208 squamous cell carcinomas, and 40 large cell carcinomas completely resected. No significant prognostic differences were seen among three groups with smaller-sized tumors (≤2 cm [n = 171], 2.1 to 3 cm [n = 202], and 3.1 to 5 cm [n = 170]); however, patients with a tumor size greater than 5 cm (n = 60) showed a significantly worse prognosis. The 5-year survival rates were 79.6%, 72.7%, 68.1%, and 46.6%, respectively, in these four groups. Multivariate analysis showed the tumor size to be an independent prognostic predictor in patients with pN0 tumors.

CONCLUSIONS: We found that a tumor size of greater than 5 cm was an independent prognostic predictor in pN0 disease; therefore, upgrading the T factor of tumor diameter to greater than 5 cm may be necessary in the next reversion of the TNM staging system.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Miyoshi, S. Moriyama, T. Kunitomo, and S. Nawa
Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 429 - 434.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. Tsuchiya, S. Hashizume, S. Akamine, M. Muraoka, S. Honda, K. Tsuji, S. Urabe, T. Hayashi, N. Yamasaki, and T. Nagayasu
Upstaging by Vessel Invasion Improves the Pathology Staging System of Non-Small Cell Lung Cancer
Chest, July 1, 2007; 132(1): 170 - 177.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Ohta, R. Waseda, H. Minato, N. Endo, Y. Shimizu, I. Matsumoto, and G. Watanabe
Surgical Results in T2N0M0 Nonsmall Cell Lung Cancer Patients With Large Tumors 5 cm or Greater in Diameter: What Regulates Outcome?
Ann. Thorac. Surg., October 1, 2006; 82(4): 1180 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. M. Heyer, T. Kagel, S. P. Lemburg, J. W. Walter, J. de Zeeuw, K. Junker, K.-M. Mueller, V. Nicolas, and T. T. Bauer
Transbronchial Biopsy Guided by Low-Dose MDCT: A New Approach for Assessment of Solitary Pulmonary Nodules
Am. J. Roentgenol., October 1, 2006; 187(4): 933 - 939.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Asamura, T. Goya, Y. Koshiishi, Y. Sohara, R. Tsuchiya, E. Miyaoka, and The Japanese Joint Committee of Lung Cancer Regist
How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations.
J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 316 - 319.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Inoue, M. Minami, H. Shiono, N. Sawabata, K. Ideguchi, and M. Okumura
Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: Pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 988 - 993.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.